Cargando…

Hepatitis C Treatment: Trial by Design

Detalles Bibliográficos
Autor principal:	Bzeizi, Khalid I.
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2008
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702906/ https://www.ncbi.nlm.nih.gov/pubmed/19568499 http://dx.doi.org/10.4103/1319-3767.39617

Ejemplares similares

Coincidence of Acute Brucella Hepatitis and Dengue Fever or Serologic Cross-reactivity?
por: Bzeizi, Khalid I., et al.
Publicado: (2010)

Statins in the Treatment of Hepatitis C
por: Vere, Cristin Constantin, et al.
Publicado: (2012)

Changing trends in liver transplantation indications in Saudi Arabia: from hepatitis C virus infection to nonalcoholic fatty liver disease
por: Alqahtani, Saleh A., et al.
Publicado: (2021)

Hepatitis C and pulmonary fibrosis: Hepatitis C and pulmonary fibrosis
por: Aliannejad, Rasoul, et al.
Publicado: (2011)

Pegylated Interferon and Ribavirin Treatment for Hepatitis C Virus Infection
por: Kagawa, Tatehiro, et al.
Publicado: (2010)

Addressing the Challenges of Hepatitis C Virus Resistance and Treatment Failure
por: Colpitts, Che C., et al.
Publicado: (2016)

Treatment of people diagnosed with chronic hepatitis C virus infection
por: Bulterys, Marc, et al.
Publicado: (2018)

Advances in the diagnosis and treatment of viral hepatitis B and C in China
por: Jia, Jidong
Publicado: (2022)

Occult Hepatitis C Infection Should Be More Noticed With New Treatment Strategies
por: Rezaee Zavareh, Mohammad Saeid, et al.
Publicado: (2015)

Treatment of Adolescents With Chronic Hepatitis C Virus Infection: New Regimen on the Block
por: Indolfi, Giuseppe, et al.
Publicado: (2018)

Treatment Guidelines in Bipolar Disorders and the Importance of Proper Clinical Trial Design
por: Tohen, Mauricio
Publicado: (2017)

Type of Pegylated Interferon Matters: Another Milestone in the Treatment of Hepatitis C Virus Infection
por: Singal, Ashwani Kumar
Publicado: (2010)

Recent Advances in Locoregional Therapy of Hepatocellular Carcinoma
por: Podlasek, Anna, et al.
Publicado: (2023)

Screening Strategies for Hepatitis C Virus
por: Lim, Aaron G., et al.
Publicado: (2019)

Revisiting the Elusive Hepatitis C Vaccine
por: Todryk, Stephen M., et al.
Publicado: (2021)

Impact of ribavirin dose reduction during treatment in chronic hepatitis C genotype 1 patients
por: Chung, Woo Jin
Publicado: (2012)

Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments?
por: Adinolfi, Luigi Elio, et al.
Publicado: (2018)

Equipoise and the technology curve: Relevance in the design of Surgical trials
por: Simpson, A. H. R. W., et al.
Publicado: (2016)

Takayasu's Arteritis and Liver Transplantation: Association and Implications
por: Alokaily, Fahdah, et al.
Publicado: (2015)

Hepatitis B and C Viruses and Hepatocellular Carcinoma
por: Bartosch, Birke
Publicado: (2010)

Extrahepatic manifestations in hepatitis C virus infection
por: Negro, Francesco, et al.
Publicado: (2017)

Hepatitis C: the challenges to link patients to the cure
Publicado: (2019)

The Challenging Road to Hepatitis C Virus Eradication
por: Martínez, Isidoro, et al.
Publicado: (2021)

Chronic Hepatitis C: Pathophysiology and Clinical Issues
por: Abate, Maria Lorena, et al.
Publicado: (2022)

Hepatocellular Carcinoma Recurrence and Mortality Rate Post Liver Transplantation: Meta-Analysis and Systematic Review of Real-World Evidence
por: Bzeizi, Khalid I., et al.
Publicado: (2022)

Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2017)

Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors
por: Broering, Dieter, et al.
Publicado: (2021)

Treatment of chronic hepatitis C patients not responding to combination therapy with ribavirin and interferon α — hype or hope?
por: Vogel, Wolfgang
Publicado: (2004)

Editorial: Effective Direct-Acting Antiviral Treatments Support Global and National Programs to Eliminate Hepatitis C
por: Parums, Dinah V.
Publicado: (2023)

Is direct-acting antiviral treatment beneficial or harmful for patients with hepatitis C virus-related hepatocellular carcinoma?
por: Lee, Hye Won
Publicado: (2022)

Diminished accuracy of biomarkers of fibrosis in low replicative chronic hepatitis B
por: Sanai, Faisal M., et al.
Publicado: (2017)

Treatment of Chronic Delta Hepatitis
por: Rizzetto, Mario
Publicado: (2011)

The Impact of Host Factors on Management of Hepatitis C Virus
por: Khattab, Mahmoud Aboelneen, et al.
Publicado: (2012)

Intravenous Drug Use and Hepatitis C Virus in Iran
por: Zobeiri, Mehdi, et al.
Publicado: (2012)

Hepatitis C Virus and Lichen Planus: The Real Association
por: Mahboobi, Nima, et al.
Publicado: (2010)

New globally faces of hepatitis B and C in the world
por: Alavian, Seyed-Moayed
Publicado: (2011)

Impact of hepatitis C oral therapy in portal hypertension
por: Libânio, Diogo, et al.
Publicado: (2017)

Hepatitis C in injection drug users: It is time to treat
por: Grassi, Alberto, et al.
Publicado: (2017)

Elimination of hepatitis C: What would be the practical approach?
por: Yim, Hyung Joon
Publicado: (2021)

The hunt for a vaccine for hepatitis C virus continues
por: The Lancet Gastroenterology & Hepatology
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0o2bb91b8n15pe38b3tr9rgp1c